That only BH nanoparticles accumulated in substantial amounts in any tumors, and that all HER2+ tumors showed BH retention, led to a hypothesis that perhaps antibody-antigen binding to cancer cell membranes of HER2+ tumors was a factor. This evidence concerns the gene ERBB2 and cancer.